New York treatment providers and policymakers met Tuesday, October 27, to explore the real-life benefits and challenges surrounding new regulations for the treatment of opioid use disorder (OUD) at a symposium hosted by Coalition of Medication-Assisted Treatment Providers and Advocates of New York State (COMPA). The symposium, titled, “Evaluating the Effects of New Regulations and...Continue Reading
It has now been two years since new final regulations from SAMHSA and the DEA regarding buprenorphine and methadone provided greater flexibilities for the treatment of Opioid Use Disorder (OUD). The Coalition of Medication-Assisted Treatment Providers and Advocates (COMPA) is hosting a full-day symposium to examine the impact of those changes, the first set of...Continue Reading